Flex Updates FY27 Guidance

Flex (FLEX) raised its fiscal 2027 guidance, expecting adjusted EPS of $4.84-$5.16 (up from $4.42-$4.74) and net sales of $34.9B-$35.9B (up from $33.7B-$35.2B). Q3 expectations are net sales of $8.87B-$9.17B and adjusted EPS of $1.19-$1.25. Q2 earnings were $0.70 per share, with revenue up 24.8% to $8.491B. Shares rose 9.38% in pre-market trading.

Original reporting
Published Oct 28, 2026, 11:40 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 28, 2026, 1:16 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$FLEX
Bullish
high confidence
Mentioned
$FLEX
Relevance
8/10
AlphAI data visualization · based on rttnews.com
Decision brief

The 30-second read

$FLEXBullishHigh
01

Why it matters

The guidance upgrade signals stronger demand and pricing power, likely encouraging short‑term buying. However, execution risk remains.

02

Market read

Primary corporate news with material numbers and immediate price reaction; high relevance for traders.

03

What to watch

Potential supply‑chain constraints and foreign‑exchange volatility could temper the upside.

Relevance 8/10Novelty 8/10Timing: pre‑market today

Background

Flex (NASDAQ: FLEX) is a contract manufacturer serving multiple technology sectors. The company released its FY27 outlook ahead of the usual schedule, prompting a notable pre‑market price move.

Company-level read

Ticker impact

$FLEXBullishHigh confidence
Context

Flex issued new FY27 guidance with higher EPS and sales forecasts, and its shares jumped 9.38% pre‑market.

Expected impact

upward pressure as investors price in stronger earnings outlook

Evidence & confidence

The guidance lift is a primary disclosure for a large‑cap US listed company, and the stock already reacted positively in pre‑market trading.

Market effects

Higher guidance may lift the broader electronics manufacturing and contract manufacturing sector.

U.S. markets could see a modest boost in related tech stocks.

Limited to investors tracking U.S. contract manufacturers.

Counterpoint

The guidance could be overly optimistic if macro demand softens, risking a future pull‑back.

Key entities

  • Flex Ltd.

    U.S. listed contract manufacturer providing the guidance update.

Related articles

$FLEXMed

Why is Flex stock climbing today?

Flex Ltd. shares rose 0.8% in pre-market trading after its subsidiary, Axiom, secured a $4.565B credit agreement with Citibank, seen as a step toward Axiom's separation. The deal includes revolving and term loans, with proceeds funding a dividend to Flex. Raymond James reiterated its Outperform rating and $150 price target for Flex. The gains occurred amid recovering U.S. equity futures.

$FLEXMed

Flex stock gains as Axiom subsidiary secures $4.6B credit

Flex Ltd (FLEX) shares rose 2.8% premarket after its subsidiary Axiom secured $4.565B in credit facilities, including a $1.265B revolving credit line and $3.3B in term loans. The funds are pending Axiom's separation from Flex and will support a dividend to Flex for debt prepayment. The loans have floating interest rates and require Axiom to maintain specific leverage and interest coverage ratios.

$FLEXMed

India says Xiaomi, Flextronics hid royalty deals in tariff fight

India accuses Xiaomi and Flex of hiding royalty deals in a tax dispute. The government claims Xiaomi's India unit failed to fully disclose royalty agreements, potentially costing it over $150 million. The case is seen as a test for India's stance on contract manufacturing. Both Xiaomi and Flex have challenged the tax tribunal's rulings, but the government seeks to dismiss these challenges.

$FLEXHigh

KeyBanc cuts Flex stock price target on valuation update

KeyBanc reduced its price target for Flex Ltd. (FLEX) to $128 from $180, citing valuation updates and peer multiple compression. The stock is down 53% from its 52-week high. Flex reported stronger-than-expected Q2 earnings and raised its full-year outlook, leading BofA Securities to raise its target to $162. The company's revenue guidance was increased by $950 million, partly due to recent acquisitions.

$FLEXMedAI 8/10

Flex Outlines FY29 Targets and Axiom’s Growth Plans at Innovation Day

Flex Ltd. outlined FY29 targets and growth plans for Axiom, its planned spin-off. Flex aims for 35-40% revenue from high-value markets, 7%+ adjusted operating margin, and double-digit adjusted EPS growth. Axiom targets $37B+ revenue by 2030, high-teens EBITDA margin, and 90%+ free cash flow conversion. The spin-off is expected in Q1 2027, subject to approvals.